Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis

NCT00622700 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

618

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Teriflunomide
DRUG: Placebo

Sponsor

Sanofi